Apitraz 500 mg Bee-hive Strips for Honey Bees

국가: 영국

언어: 영어

출처: VMD (Veterinary Medicines Directorate)

유효 성분:

Amitraz

제공처:

Laboratorios Calier, SA

ATC 코드:

QP53AD01

INN (International Name):

Amitraz

약제 형태:

Bee-hive strip

처방전 유형:

AVM-GSL - Authorised Veterinary Medicine – General Sales List

치료 그룹:

Honey bees

치료 영역:

Ectoparasiticide

승인 상태:

Authorized

승인 날짜:

2016-04-26

제품 특성 요약

Revised: April 2023
AN: 01060/2022
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Apitraz 500 mg bee-hive strips for honey bees
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 27.6 g strip contains:
ACTIVE SUBSTANCE:
Amitraz...................................500 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Bee-hive strip
White rectangular plastic strip with two tabs and a marker fold line.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Honey bees – _Apis mellifera_
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of external parasitosis in honey bees caused by _Varroa
destructor _.
4.3
CONTRAINDICATIONS
None
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
All colonies in the same apiary should be treated simultaneously to
avoid reinfestation
by robbery.
Do not re-use the strips_. _
It is recommended not to use the product before the end of the honey
producing season
of the year. See also section 4.9 for Precautions of use and
application timetable and
4.11 for withdrawal periods.
Revised: April 2023
AN: 01060/2022
Page 2 of 7
Bee colonies should be monitored routinely for the level of varroa
mite infestation
during treatment and also for a period thereafter.
The product should be used as part of an integrated varroa control
program.
Inappropriate use of the product could result in an increased risk of
resistance
development and could ultimately result in ineffective therapy.
Amitraz resistance has been reported in some populations of Varroa
mites.
In countries with recognized amitraz resistance or in case of
suspicion of amitraz
resistance, the use of the product should ideally be based on results
of susceptibility
testing (e.g. Beltsville test). Please speak to your veterinarian or
local bee inspector
for further information.
The safety and efficacy of the veterinary medicinal product has only
been
investigated in hives with a single brood chamber (dose of 2 strips
per hive/brood
chamber). No information is available on the sa